Clinical trial
Study of Desmoteplase (International Nonproprietary Name [INN]) in Acute…
NCT00111852 · Forest Laboratories, Industry · Completed
Key facts
| NCT number | NCT00111852 |
|---|---|
| Title | Study of Desmoteplase (International Nonproprietary Name [INN]) in Acute Ischemic Stroke (DIAS-2) |
| Official title | A Prospective, Randomized, Double-blind, Placebo-controlled, Single Bolus, Multinational, Multi-center, Parallel Group, Dose-ranging Study of Desmoteplase (INN) in the Indication of Acute Stroke |
| Lead sponsor | Forest Laboratories, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Stroke, Acute |
| Intervention type | Drug |
| Interventions | Desmoteplase, Placebo |
| Enrollment | 193 |
| Start date | Apr 1, 2005 |
| Primary completion | Mar 1, 2007 |
| First posted | May 27, 2005 |
| Last update posted | Mar 20, 2012 |
| Countries | Australia, Austria, Canada, Finland, Germany, Netherlands, Spain, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: